{"slideshow_credits": null, "snippet": "The Pharmaceutical Research and Manufacturers of America responds to an editorial.", "abstract": null, "section_name": "Opinion", "print_page": "20", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2013/05/04/opinion/cost-of-cancer-drugs.html", "lead_paragraph": "The Pharmaceutical Research and Manufacturers of America responds to an editorial.", "headline": {"main": "Cost of Cancer Drugs", "print_headline": "Cost of Cancer Drugs", "content_kicker": "Letter", "kicker": "Letter"}, "_id": "51844c8ecf28d05efe0009de", "word_count": "177", "multimedia": [], "pub_date": "2013-05-04T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Cancer", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Longevity", "name": "subject", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}